Prospects of vaccines for medically important fungi Is a vaccine needed againstCandidaalbicans?
Author(s) -
A. Brian Mochon,
Jim E. Cutler
Publication year - 2005
Publication title -
medical mycology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.004
H-Index - 86
eISSN - 1460-2709
pISSN - 1369-3786
DOI - 10.1080/13693780500035979
Subject(s) - candida albicans , microbiology and biotechnology , immunity , chronic mucocutaneous candidiasis , biology , sensitization , immunology , organism , mucocutaneous zone , candida infections , disease , immune system , medicine , pathology , paleontology
The development of a useful Candida vaccine is a distinct possibility despite the fact that individuals with a lifetime of commensal sensitization do not develop sterile immunity to the organism. An effective Candida vaccine would be invaluable in preventing hematogenously disseminated candidiasis, as well as mucocutaneous disease. This review is a discussion of our current understanding of the interplay between commensal and pathogenic forms of Candida albicans and approaches toward active and passive immunoprevention against candidiasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom